[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE9600046D0 - New pharmaceutical formulation - Google Patents

New pharmaceutical formulation

Info

Publication number
SE9600046D0
SE9600046D0 SE9600046A SE9600046A SE9600046D0 SE 9600046 D0 SE9600046 D0 SE 9600046D0 SE 9600046 A SE9600046 A SE 9600046A SE 9600046 A SE9600046 A SE 9600046A SE 9600046 D0 SE9600046 D0 SE 9600046D0
Authority
SE
Sweden
Prior art keywords
beads
furosemide
minutes
controlled release
pharmaceutical formulation
Prior art date
Application number
SE9600046A
Other languages
English (en)
Inventor
Hans Arwidsson
Maria Eriksson
Lars Stubberud
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9600046A priority Critical patent/SE9600046D0/sv
Publication of SE9600046D0 publication Critical patent/SE9600046D0/sv
Priority to PCT/SE1996/001734 priority patent/WO1997025028A1/en
Priority to AU13238/97A priority patent/AU1323897A/en
Priority to ZA9610888A priority patent/ZA9610888B/xx
Priority to MA24443A priority patent/MA26416A1/fr
Priority to HRP970004 priority patent/HRP970004A2/hr
Priority to TNTNSN97001A priority patent/TNSN97001A1/fr

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE9600046A 1996-01-05 1996-01-05 New pharmaceutical formulation SE9600046D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9600046A SE9600046D0 (sv) 1996-01-05 1996-01-05 New pharmaceutical formulation
PCT/SE1996/001734 WO1997025028A1 (en) 1996-01-05 1996-12-20 Pharmaceutical controlled release beads comprising furosemide and a formulation containing said controlled release beads
AU13238/97A AU1323897A (en) 1996-01-05 1996-12-20 Pharmaceutical controlled release beads comprising furosemide and a formulation containing said controlled release beads
ZA9610888A ZA9610888B (en) 1996-01-05 1996-12-23 Pharmaceutical controlled release beads comprising furosemide and a formulation containing said controlled release beads
MA24443A MA26416A1 (fr) 1996-01-05 1996-12-26 Perles pharmaceutiques a liberation controlee contenant du furosemide et une composition realisee avec les dites perles.
HRP970004 HRP970004A2 (en) 1996-01-05 1997-01-03 Pharmaceutically controlled release of beads comprising furosemide and a formulation containing said controlled release beads
TNTNSN97001A TNSN97001A1 (fr) 1996-01-05 1997-01-03 Perles pharmaceutiques a liberation controlee contenant du furosemide, et une composition realisee avec les dites perles.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9600046A SE9600046D0 (sv) 1996-01-05 1996-01-05 New pharmaceutical formulation

Publications (1)

Publication Number Publication Date
SE9600046D0 true SE9600046D0 (sv) 1996-01-05

Family

ID=20400947

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9600046A SE9600046D0 (sv) 1996-01-05 1996-01-05 New pharmaceutical formulation

Country Status (7)

Country Link
AU (1) AU1323897A (sv)
HR (1) HRP970004A2 (sv)
MA (1) MA26416A1 (sv)
SE (1) SE9600046D0 (sv)
TN (1) TNSN97001A1 (sv)
WO (1) WO1997025028A1 (sv)
ZA (1) ZA9610888B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1126826B3 (en) 1998-11-02 2019-05-15 Alkermes Pharma Ireland Limited Multiparticulate modified release composition of methylphenidate
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
EP2295043A1 (en) 1999-10-29 2011-03-16 Euro-Celtique S.A. Controlled release hydrocodone formulations
CN100518827C (zh) 2000-10-30 2009-07-29 欧罗赛铁克股份有限公司 控释氢可酮制剂
US20030091633A1 (en) * 2001-11-15 2003-05-15 John Kelly Methods and compositions for use of (S)-bisoprolol
IL160095A0 (en) * 2004-01-28 2004-06-20 Yissum Res Dev Co Formulations for poorly soluble drugs
ATE469650T1 (de) * 2004-12-01 2010-06-15 Par Pharmaceuticals Inc Verwendung von megestrolacetat zur verbesserung der herzfunktion und zur behandlung von herzinsuffizienz
WO2009145716A1 (en) * 2008-05-28 2009-12-03 Astrazeneca Ab New pharmaceutical formulation useful in gerd therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US4938968A (en) * 1988-07-26 1990-07-03 Norjec Development Associates, Inc. Controlled release indomethacin
NZ230763A (en) * 1988-09-27 1991-10-25 Takeda Chemical Industries Ltd Production of granules having a core by spraying the cores with a dispersion of hydroxypropylcellulose, optionally incorporating an active ingredient

Also Published As

Publication number Publication date
HRP970004A2 (en) 1998-04-30
AU1323897A (en) 1997-08-01
ZA9610888B (en) 1997-07-07
WO1997025028A1 (en) 1997-07-17
TNSN97001A1 (fr) 2005-03-15
MA26416A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
DE69521987T2 (de) Amoxicillin zweischichttabletten
BR9915087A (pt) Formulação farmacêutica oral revestida entérica, uso de uma qualidade de hidroxipropil celulose (hpc), processo para a munufatura de uma formulação farmacêutica oral revestida entérica, uso de uma formulação farmacêutica, e, método para o tratamento de doenças gastrointestinais em mamìferos, incluindo o homem
US5885615A (en) Pharmaceutical controlled release tablets containing a carrier made of cross-linked amylose and hydroxypropylmethylcellulose
JP2750150B2 (ja) 改良されたコアー膜付着性質を有する医薬的に許容される活性剤を含む浸透性連続分散性経口投写システム
JPH06172162A (ja) 活性物質の制御された速度の放出を備えた錠剤
US6221395B1 (en) Controlled release pharmaceutical tablets containing an active principle of low water solubility
RU99108461A (ru) Лекарственная форма для перорального введения с отложенным немедленным высвобождением и способ ее приготовления
SE9600046D0 (sv) New pharmaceutical formulation
DE873750T1 (de) Bioadhäsive Tabletten
JP2003528910A (ja) 制御放出性製剤の製法
KR20040063909A (ko) 구강, 비강 또는 질강에 항박테리아성, 항진균성, 및항바이러스성 연고를 전달하는 조성물과 방법
CN110891552B (zh) 肠溶性硬质胶囊
CA2451135A1 (en) Method of manufacturing tablet
EP0213083A3 (en) Controlled release tablet
JPS62223113A (ja) 歯周病治療剤
DK2332523T3 (da) Ensartede film til hurtigtopløsende doseringsform indeholdende smagsmaskerende præparater
Schultz et al. A new multiparticulate delayed release system.: Part II: Coating formulation and properties of free films
JPH0363223A (ja) エストラジオール組成物及びその局所施用方法
BR9807368A (pt) Comprimidos de oxacarvazepina revestidos com pelìcula
DE69407404D1 (de) Feste zubereitung mit hoher freisetzung, ihre herstellung und verwendung
ATE247457T1 (de) Stabile arzneiform mit benzimidazolderivaten als wirkstoff zur oralen verabreichung und verfahren zu ihrer herstellung
EP2072043A3 (en) Mesalazine tablet
MXPA02009797A (es) Preparaciones farmaceuticas y su manufactura.
JPH0454107A (ja) シート状パック剤
JPS5810734A (ja) 固形状レリ−フ型作成用感光性樹脂積層体